Biotech stocks are mostly driven by clinical trial results and regulatory decisions. Listed below are some of the companies that await FDA decision or are expected to report their clinical trial results *this month (if the companies stick to their timeline).
from RTT - Biotech http://bit.ly/2H2MhHs
via IFTTT
No comments:
Post a Comment